Document is current
Any future updates will be listed below
-
Authors
Wahab, Noorul
Toss, Michael
Miligy, Islam M.
Jahanifar, Mostafa
Atallah, Nehal M.
Lu, Wenqi
Graham, Simon
Bilal, Mohsin
Bhalerao, Abhir
Lashen, Ayat G. https://orcid.org/0000-0001-9494-7382
Makhlouf, Shorouk https://orcid.org/0000-0003-3889-9659
Ibrahim, Asmaa Y.
Snead, David
Minhas, Fayyaz https://orcid.org/0000-0001-9129-1189
Raza, Shan E. Ahmed https://orcid.org/0000-0002-1097-1738
Rakha, Emad
Rajpoot, Nasir https://orcid.org/0000-0002-4706-1308
-
Funding
Funding for this research was provided by:
Innovate UK (104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689, 104689)
- License Information
-
More Information
Article History
Received: 19 May 2023
Accepted: 24 October 2023
First Online: 15 November 2023
Competing interests
: S.G., D.S. and N.R. are co-founders of Histofy Ltd. F.M., S.G., D.S. and N.R. are shareholders in Histofy Ltd. F.M. and N.R. report research funding from GlaxoSmithKline. N.R. is also in receipt of research funding from AstraZeneca. The other authors declare no competing interests.
